Aaron I. Davis

Insider Reports History

Entity
Individual
Location
12860 El Camino Real, Suite 300, San Diego, California
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron I. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Director Common Stock 6.99M $58.6M $8.39 Jun 6, 2023 Indirect
Odonate Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.61M $7.23M $1.57 Nov 19, 2021 Indirect
Odonate Therapeutics, Inc. Director, 10%+ Owner Common Stock 446K $699K $1.57 Nov 19, 2021 Direct
Tango Therapeutics, Inc. Director Common Stock 5K $42K $8.39 Jun 6, 2023 Direct
Rain Oncology Inc. Director Common Stock, par value $0.001 per share 0 $0 $1.21 Jan 26, 2024 Direct
Tango Therapeutics, Inc. Director Stock Option (Right to Buy) 30K Jun 6, 2023 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 24.2K Jun 11, 2024 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 Jan 23, 2024 Direct
Rain Oncology Inc. Director Stock Option (Right to Buy) 0 Jan 26, 2024 Direct

Insider Reports Filed by Aaron I. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITOS iTeos Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
RAIN Rain Oncology Inc. Jan 26, 2024 3 $0 4 Jan 26, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 6 $0 4 Jan 23, 2024 Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $400K 4 Jan 3, 2024 Director
RAIN Rain Oncology Inc. Aug 9, 2023 1 $0 4 Aug 11, 2023 Director
ITOS iTeos Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
TNGX Tango Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Director, 10%+ Owner
RAIN Rain Therapeutics Inc. Nov 4, 2022 2 $8M 4 Nov 8, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
TNGX Tango Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 28, 2022 Director
RAIN Rain Therapeutics Inc. Jun 1, 2022 1 $0 4 Aug 19, 2022 Director
ITOS iTeos Therapeutics, Inc. May 9, 2022 6 -$13.9M 4 May 11, 2022 Director
ITOS iTeos Therapeutics, Inc. Apr 28, 2022 5 -$10.2M 4 May 2, 2022 Director
ITOS iTeos Therapeutics, Inc. Mar 22, 2022 4 $1.63M 4 Mar 24, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Director, 10%+ Owner
ODT Odonate Therapeutics, Inc. Nov 17, 2021 5 -$2.5M 4 Nov 19, 2021 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director